secwatch.observer — SEC 8-K summary
======================================

Issuer:     BALCHEM CORP (BCPC)
CIK:        0000009326
Form:       8-K
Filed at:   2024-10-25T23:59:59+00:00
Accession:  0001628280-24-043760
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Balchem Q3 net sales up 4.3% to $239.9M; record adjusted EBITDA $64.4M, up 7.6% YoY
--------------------------------------------------------------------------------

- GAAP EPS $1.03 versus $0.90 prior year; adjusted EPS record $1.13 versus $1.04.
- Human Nutrition & Health and Specialty Products segments drove strong sales and earnings growth.
- Cash from operations $51.3M; free cash flow $42.2M; repaid $39.6M revolving debt, net debt $153.3M (0.6x leverage).
- Launched K2Vital Delta Fermented, VitaCholine Pro-Flo, and AminoShure-XL during the quarter.
- Year-to-date 2024 net earnings $94.9M vs $81.9M; net sales $713.7M vs $693.7M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/9326/000162828024043760/0001628280-24-043760-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/9326/000162828024043760/bcpc-20241025.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-043760

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer